HPV-16 and HPV-18 L1 capsid protein — Drug Target

All drugs that target HPV-16 and HPV-18 L1 capsid protein — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Prophylactic vaccine

Phase 3 pipeline (1)

• HPV-16/18 L1 VLP AS04 · GlaxoSmithKline · Prophylactic vaccine · Oncology / Immunology
  This vaccine stimulates the immune system to produce antibodies against HPV-16 and HPV-18 virus-like particles, preventing infection and cervical cancer development.